ArticleAIDS (London, England)2025

Target trials of preconception switch from nevirapine or efavirenz-based antiretroviral therapy to dolutegravir-based antiretroviral therapy on adverse birth and maternal outcomes.

Ellen C Caniglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.